1,700,000 Shares in ASP Isotopes Inc. (NASDAQ:ASPI) Purchased by Telemark Asset Management LLC

Telemark Asset Management LLC purchased a new position in shares of ASP Isotopes Inc. (NASDAQ:ASPI) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 1,700,000 shares of the company’s stock, valued at approximately $4,726,000. Telemark Asset Management LLC owned 2.39% of ASP Isotopes as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. Charles Schwab Investment Management Inc. lifted its position in shares of ASP Isotopes by 16.6% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 120,278 shares of the company’s stock worth $334,000 after buying an additional 17,159 shares during the period. BNP PARIBAS ASSET MANAGEMENT Holding S.A. acquired a new position in ASP Isotopes during the third quarter worth $6,249,000. GSA Capital Partners LLP lifted its holdings in shares of ASP Isotopes by 96.0% during the third quarter. GSA Capital Partners LLP now owns 770,989 shares of the company’s stock valued at $2,143,000 after acquiring an additional 377,721 shares during the period. Fiera Capital Corp acquired a new stake in shares of ASP Isotopes in the 3rd quarter valued at $723,000. Finally, Marshall Wace LLP grew its holdings in shares of ASP Isotopes by 389.6% in the 2nd quarter. Marshall Wace LLP now owns 545,072 shares of the company’s stock worth $1,668,000 after purchasing an additional 433,734 shares during the last quarter. 16.80% of the stock is owned by institutional investors and hedge funds.

ASP Isotopes Trading Up 7.5 %

Shares of NASDAQ ASPI opened at $7.69 on Friday. ASP Isotopes Inc. has a 1-year low of $1.59 and a 1-year high of $9.33. The company has a 50-day moving average of $4.75 and a two-hundred day moving average of $3.80. The company has a market cap of $546.86 million, a PE ratio of -11.93 and a beta of 3.88. The company has a current ratio of 4.00, a quick ratio of 4.00 and a debt-to-equity ratio of 2.06.

ASP Isotopes (NASDAQ:ASPI) last posted its quarterly earnings data on Monday, August 19th. The company reported ($0.24) earnings per share for the quarter. The company had revenue of $1.02 million during the quarter. ASP Isotopes had a negative return on equity of 177.29% and a negative net margin of 807.39%. As a group, equities analysts expect that ASP Isotopes Inc. will post -0.24 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts have commented on ASPI shares. Canaccord Genuity Group began coverage on shares of ASP Isotopes in a research report on Friday, October 4th. They issued a “buy” rating and a $4.50 price target on the stock. Canaccord Genuity Group restated a “buy” rating and set a $4.50 price target on shares of ASP Isotopes in a research report on Friday, October 18th. Finally, HC Wainwright cut their price objective on ASP Isotopes from $5.50 to $4.50 and set a “buy” rating for the company in a research report on Wednesday, August 7th.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.